Disruption of pRb-p16INK4 pathway: A common event in ampullary carcinogenesis

Hepato-Gastroenterology

Volumn 52, Issue 61, 2005, Pages 55-59

  Yuan, Lian Wen ^a,b   Tang, Wei ^a   Kokudo, Norihiro ^a   Seyama, Yasuji ^a   Shi, Ya Zhou ^a   Karako, Hirona ^a   Zhao, Bin ^a   Sugawara, Yasuhiko ^a   Nagawa, Hirokazu ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Ampullary cancer; Carcinogenesis; p16INK4 protein; pRb

Indexed keywords

PROTEIN P16INK4A; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; FEMALE; GENE DISRUPTION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; VATER PAPILLA CARCINOMA; BILE DUCT TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; VATER PAPILLA;

AGED; AGED, 80 AND OVER; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETINOBLASTOMA PROTEIN; RETROSPECTIVE STUDIES;

EID: 20044379731     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Howe JR, Klimstra DS, Cordon-Cardo C, Paty PB, Park PY, Brennan MF: K-ras mutation in adenomas and carcinomas of the ampulla of vater. Clin Cancer Res 1997; 3:129-133.
2. Imai Y, Oda H, Tsurutani N, Nakatsuru Y, Inoue T, Ishikawa T: Frequent somatic mutations of the APC and p53 genes in sporadic ampullary carcinomas. Jpn J Cancer Res 1997; 88:846-854.
3. Park SH, Kim YI, Park YH, Kim SW, Kim KW, Kim YT, Kim WH: Clinicopathologic correlation of p53 protein high expression in adenoma and carcinoma of the ampulla of Vater. World J Surg 2000; 24:54-59.
4. INK4B/MTS2 genes in biliary tract cancers. Cancer Res 1995; 55:2756-2760.
5. INK4 gene mutations are relatively frequent in ampullary carcinomas. Jpn J Cancer Res 1997; 88:941-946.
6. Kamb A: Cell-cycle regulators and cancer. Trends Genet 1995; 11:136-140.
7. Sherr CJ: Cancer cell cycles. Science 1996; 274:1672-1677.
8. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 1995; 81:323-330.
9. Lipinski MM, Jacks T: The retinoblastoma gene family in differentiation and development. Oncogene 1999; 18:7873-7882.
10. INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A 1998; 95:11891-11896.
11. Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dervite I, Lai JL, Bauters F, Wattel E, Fenaux P: p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 1995; 85:657-663.
12. INK4a) gene in resected nonsmall cell lung tumors and exfoliated cells within sputum. Int J Cancer 2002; 98 724-731.
13. Li X, Hui AM, Shi YZ, Sun L, Takayama T, Makuuchi M: Deregulation of G1/S transition is a common event in carcinoma of the ampulla of Vater. Hepatogastroenterology 2002; 49:1239-1244.
14. Japanese Society of Biliary Surgery: General Rules for Surgical and Pathological Studies on Cancer of Biliary Tract, Ed.3. Tokyo: Kanehara Co., Ltd., 1993.
15. INK4 protein in gallbladder carcinomas. Clin Cancer Res 2000; 6:4096-4100.
16. INK4 protein expression in extrahepatic bile duct carcinomas. Hepatogastroenterology 2000; 47:1216-1220.
17. INK4) protein, alone and together with loss of retinoblastoma protein, correlate with hepatocellular carcinoma progression. Cancer Lett 2000; 154:93-99.
18. Wittekind C, Tannapfel A: Adenoma of the papilla and ampulla - premalignant lesions? Langenbecks Arch Surg 2001; 386:172-175.
19. Sato T, Konishi K, Kimura H, Maeda K, Yabushita K, Tsuji M, Miwa A: Adenoma and tiny carcinoma in adenoma of the papilla of Vater-p53 and PCNA. Hepatogastroenterology 1999; 46:1959-1962.
20. Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR, Howley FM: Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci U S A 1996; 93:4350-4354.
21. Li Y, Nichols MA, Shay JW, Xiong Y: Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 1994; 54:6078-6082.
22. Hu YX, Watanabe H, Ohtsubo K, Yamaguchi Y, Ha A, Okai T, Sawabu N: Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma. Clin Cancer Res 1997; 3:1473-1477.
23. INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptor. J Cell Biol 2000; 150:1467-1478.
24. Hui AM, Li X, Makuuchi M, Takayama T, Kubota K: High expression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma. Int J Cancer 1999; 84:604-608.
25. Morgenbesser SD, Williams BO, Jacks T, DePinho RA: p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994; 371:72-74.
26. Plath T, Peters M, Detjen K, Welzel M, von Marschall Z, Radke C, Wiedenmann B, Rosewicz S: High expression of pRB in human pancreatic carcinoma cells: function in chemotherapy-induced apoptosis. J Natl Cancer Inst 2002; 94:129-142.
27. Palmqvist R, Stenling R, Oberg A, Landberg G: Expression of cyclin D1 and retinoblastoma protein in colorectal cancer. Eur J Cancer 1998; 34:1575-1581.
28. Sakaguchi M, Fujii Y, Hirabayashi H, Yoon HE, Komoto Y, Oue T, Kusafuka T, Okada A, Matsuda H: Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study. Int J Cancer 1996; 65:442-445.
29. Yeager T, Stadler W, Belair C, Puthenveettil J, Olopade O, Reznikoff C: Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res 1995; 55:493-497.